Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial. - Garfinkle EAR; Perales-Linares R; Gimple RC; Livingstone AJ; Roberts KF; Butt OH; Goedegebuure SP; McLellan MD; Chang GS; Hundal J; Yan J; Navarro JB; et al. (Nature cancer, 2026)